← Leaderboards
Stefan Wildt
Glycofi, Inc.
$1,922,076
Attributed
$1,922,076
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,922,076 · 4
By mechanism
R44$1,722,076 · 2
R43$200,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionRecombinant ProteinsBiotechnologyBiotherapeutic AgentProtein EngineeringAlpha 1 AntitrypsinHigh Throughput TechnologyChimeric ProteinsEndoplasmic ReticulumGlycoproteinsGlycosylationHigh Performance Liquid ChromatographyInterferon BetaPeptide LibraryTechnology /Technique DevelopmentBioengineering /Biomedical EngineeringGolgi ApparatusDrosophilidaeMannosidaseMatrix Assisted Laser Desorption IonizationMonilialesPolymerase Chain ReactionProtein PurificationEndodeoxyribonuclease
Grant awards (5)
Replication of the Human Secretory Pathway in Yeast$731,666
R44 · FY2005 · GM
Production of Therapeutic Proteins in Lower Eukaryotes$238,348
R44 · FY2004 · GM
Replication of the Human Secretory Pathway in Yeast$100,000
R43 · FY2004 · GM
Production of Therapeutic Proteins in Lower Eukaryotes$752,062
R44 · FY2003 · GM
Production of Therapeutic Proteins in Lower Eukaryotes$100,000
R43 · FY2002 · GM